Liver's Post-Meal secrets could unlock new fatty liver treatments
NCT ID NCT03849235
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study investigates how the liver processes nutrients after a meal in healthy individuals and in patients with fatty liver disease or cirrhosis. Researchers will take blood samples and liver biopsies after fasting or eating a standardized meal, and after a glucagon injection. The goal is to understand the molecular changes in the liver, which may lead to better biomarkers and treatments for liver diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Standardised meal and glucagon bolus
- What this could lead to
- If successful, this could identify new biomarkers and targets for treating fatty liver disease and cirrhosis.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gastrounit, Copenhagen University Hospital Hvidovre
Hvidovre, Capital Region Denmark, 2650, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Can a nasal spray of insulin shield the aging brain from Post-Surgery confusion?
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Smartphone app could improve blood sugar control in type 2 diabetes